Derivatives of 6-(6-NH-substituted-triazolopyridazine-s ulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors

Details for Australian Patent Application No. 2010212233 (hide)

Owner Sanofi

Inventors Bacque, Eric; Nemecek, Conception; Ugolini, Antonio; Wentzler, Sylvie

Agent A J Park

Pub. Number AU-A-2010212233

PCT Pub. Number WO2010/089508

Priority 0900513 06.02.09 FR

Filing date 4 February 2010

Wipo publication date 12 August 2010

International Classifications

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/089508 Priority application(s): WO2010/089508

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212234-Derivatives of 6-(6-substituted-triazolopyridazine-sulfa nyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors

2010212232-Derivatives of 6-(6-O-substituted-triazolopyridazine-su lfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors